The association between body composition, leptin levels and glucose dysregulation in youth with cystic fibrosis

• Published in: Journal of cystic fibrosis 2021-09, Vol.20 (5), p.796-802
• Main Authors: Granados, Andrea, Beach, Elizabeth A, Christiansen, Andrew J., Patterson, Bruce W., Wallendorf, Michael, Arbeláez, Ana María
• Format: Article
• Language: English
• Subjects: Absorptiometry, Photon; Adiposity; Adolescent; Adult; Body Composition; Child; Cross-Sectional Studies; Cystic fibrosis; Cystic Fibrosis - metabolism; Cystic Fibrosis - physiopathology; Diabetes; Fat mass; Female; Glucose impairment; Glucose Intolerance - metabolism; Glucose Intolerance - physiopathology; Glucose Tolerance Test; Humans; Insulin Resistance; Insulin-Secreting Cells - metabolism; Lean body mass; Leptin; Leptin - metabolism; Male; Muscle mass; Young Adult
• ISSN: 1569-1993; 1873-5010; 1873-5010
• DOI: 10.1016/j.jcf.2021.06.004

•Despite new therapeutic strategies and nutritional interventions, clinically stable youth with CF have lower body fat and weight z-score.•CF patients with early onset diabetes showed the lowest fat mass and leptin levels suggesting a role of leptin in glucose dysregulation in this population.•Focusing exclusively on BMI in patients with CF when assessing nutritional status may miss important information on body composition which is a key determinant of clinical outcomes in children and adults with CF. Optimization of nutritional status is recommended in patients with cystic fibrosis (CF) given the association between lower body mass index (BMI) and poor clinical outcomes. However, higher BMI and body fat correlate with glucose impairment and higher leptin levels in the general population. Differences in body composition and leptin levels between the categories of glucose tolerance were assessed in youth with CF and healthy controls. In a cross-sectional study, 59 adolescents and young adults with CF and 15 healthy controls matched by age and gender, underwent body composition analysis using dual energy X-ray absorptiometry (DXA) and a 2-hour oral glucose tolerance test (OGTT). Measures of insulin sensitivity, β-cell insulin secretion and fasting leptin levels were obtained. Of the participants with CF, 62% were classified as abnormal glucose tolerant and 22% with cystic fibrosis related diabetes (CFRD). Patients with CFRD had a lower fat mass index (FMI) z-score, wt z-score and leptin levels compared to the control group (-1.86 vs. - 0.59, p=0.01; -1.86 vs 0.44, p=